BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Zymeworks 

540 – 1385 West 8th Avenue

Vancouver  British Columbia  V6H 3V9  Canada
Phone: 604-678-1388 Fax: 604-737-7077


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
Zymeworks Announces Strategic Collaboration With Eli Lilly and Company (LLY) Subsidiary ImClone Systems (LLY) To Develop Bi-specific Antibodies Using Zymeworks' Azymetric™ Platform 1/9/2014 8:13:24 AM    More...
Zymeworks Wraps Up $15 Million Funding Round 1/9/2014 7:00:35 AM    More...
Zymeworks Announces the Addition of Dr. Leonard Presta to its Scientific Advisory Board 8/15/2013 7:00:19 AM    More...
Zymeworks to Receive an Undisclosed Amount From Merck & Co., Inc. (MRK), Part of a $187 Million Alliance 4/16/2013 7:14:07 AM    More...
Zymeworks Raises $11 Million, Hits Antibody Drug Milestone for Merck & Co., Inc. (MRK) 9/6/2012 7:57:01 AM    More...
Zymeworks Announces the Formation of its Therapeutics Advisory Team, and Appointment of VP, Preclinical R&D to Advance its Strategic Therapeutics Initiative 1/5/2012 6:24:20 AM    More...
Zymeworks Completes $8.1 Million Round of Financing to Advance Platform Technology and Therapeutics Pipeline Programs 9/22/2011 6:39:36 AM    More...
Zymeworks Snags $187 Million Deal With Merck & Co., Inc. (MRK) to Discover Multi-Pronged Antibodies 8/29/2011 7:15:40 AM    More...
Zymeworks Closes $3.2 Million Round of Financing and Announces the Addition of Dr. Donald Drakeman to Its Board of Directors 6/29/2010 6:26:04 AM    More...
Zymeworks Appoints Computational Antibody Design Expert Dr. Bruce Tidor to its Scientific Advisory Board 10/2/2009 8:31:42 AM    More...
12

//-->